- Home
- UNB vs SGMO Comparison
UNB vs SGMO Comparison
Compare UNB & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNB
- SGMO
- Stock Information
- Founded
- UNB 1891
- SGMO 1995
- Country
- UNB United States
- SGMO United States
- Employees
- UNB N/A
- SGMO N/A
- Industry
- UNB Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UNB Finance
- SGMO Health Care
- Exchange
- UNB Nasdaq
- SGMO Nasdaq
- Market Cap
- UNB 120.8M
- SGMO 180.5M
- IPO Year
- UNB 1998
- SGMO 2000
- Fundamental
- Price
- UNB $26.70
- SGMO $0.94
- Analyst Decision
- UNB
- SGMO Buy
- Analyst Count
- UNB 0
- SGMO 4
- Target Price
- UNB N/A
- SGMO $2.67
- AVG Volume (30 Days)
- UNB 4.2K
- SGMO 2.5M
- Earning Date
- UNB 10-16-2024
- SGMO 10-30-2024
- Dividend Yield
- UNB 5.52%
- SGMO N/A
- EPS Growth
- UNB N/A
- SGMO N/A
- EPS
- UNB 2.20
- SGMO N/A
- Revenue
- UNB $47,529,000.00
- SGMO $12,277,000.00
- Revenue This Year
- UNB N/A
- SGMO N/A
- Revenue Next Year
- UNB N/A
- SGMO $52.02
- P/E Ratio
- UNB $12.13
- SGMO N/A
- Revenue Growth
- UNB N/A
- SGMO N/A
- 52 Week Low
- UNB $21.00
- SGMO $0.29
- 52 Week High
- UNB $32.00
- SGMO $1.48
- Technical
- Relative Strength Index (RSI)
- UNB 56.50
- SGMO 58.17
- Support Level
- UNB $26.00
- SGMO $0.77
- Resistance Level
- UNB $26.99
- SGMO $1.07
- Average True Range (ATR)
- UNB 0.55
- SGMO 0.07
- MACD
- UNB 0.05
- SGMO 0.01
- Stochastic Oscillator
- UNB 88.02
- SGMO 59.30
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group. Geographically, all the business activity is functioned through the United States.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.